Bio-Gate AG (XTER:BIG1) Total Equity : €3.45 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Total Equity?

Bio-Gate AG's total equity for the quarter that ended in Dec. 2023 was €3.45 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bio-Gate AG Total Equity Historical Data

The historical data trend for Bio-Gate AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Total Equity Chart

Bio-Gate AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

1.69

1.55

3.77

4.25

3.45

Bio-Gate AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Equity	Get a 7-Day Free Trial															3.77	2.71	4.25	3.54	3.45

Bio-Gate AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bio-Gate AG's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	5.259	-	1.808
	=	3.45

Bio-Gate AG's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	5.259	-	1.808
	=	3.45

Bio-Gate AG Total Equity Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gate AG (XTER:BIG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

BIG1:Germany BIG1:Germany

Address

Neumeyerstraße 28-34, Nürnberg, DEU

Website

http://www.biogate.de

Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.

Executives

Karl Richter

Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines